282 related articles for article (PubMed ID: 36076204)
61. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
Lover AA; Dantzer E; Hongvanthong B; Chindavongsa K; Welty S; Reza T; Khim N; Menard D; Bennett A
Malar J; 2018 Jun; 17(1):218. PubMed ID: 29859089
[TBL] [Abstract][Full Text] [Related]
62. The reality of using primaquine.
Burgoine KL; Bancone G; Nosten F
Malar J; 2010 Dec; 9():376. PubMed ID: 21184691
[TBL] [Abstract][Full Text] [Related]
63. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
[TBL] [Abstract][Full Text] [Related]
64. Prevalence and molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Senoi Malaysian Orang Asli population.
Xuan-Rong Koh D; Zailani MAH; Raja Sabudin RZA; Muniandy S; Muhamad Hata NAA; Mohd Noor SNB; Zakaria N; Othman A; Ismail E
PLoS One; 2023; 18(12):e0294891. PubMed ID: 38085718
[TBL] [Abstract][Full Text] [Related]
65. Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia.
Adhikari B; Tripura R; Dysoley L; Callery JJ; Peto TJ; Heng C; Vanda T; Simvieng O; Cassidy-Seyoum S; Ley B; Thriemer K; Dondorp AM; von Seidlein L
Malar J; 2022 Oct; 21(1):282. PubMed ID: 36195916
[TBL] [Abstract][Full Text] [Related]
66. Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency among Malaria Patients in Southern Thailand: 8 Years Retrospective Study.
Khammanee T; Sawangjaroen N; Buncherd H; Tun AW; Thanapongpichat S
Korean J Parasitol; 2022 Feb; 60(1):15-23. PubMed ID: 35247950
[TBL] [Abstract][Full Text] [Related]
67. G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.
Ley B; Alam MS; Thriemer K; Hossain MS; Kibria MG; Auburn S; Poirot E; Price RN; Khan WA
PLoS One; 2016; 11(4):e0154015. PubMed ID: 27128675
[TBL] [Abstract][Full Text] [Related]
68. The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
Tang ASO; Soo XY; Yeo ST; Mansor NA; Chew LP; Chua HH
J R Coll Physicians Edinb; 2021 Jun; 51(2):146-148. PubMed ID: 34131671
[TBL] [Abstract][Full Text] [Related]
69. Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
Chamchoy K; Sudsumrit S; Thita T; Krudsood S; Patrapuvich R; Boonyuen U
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010986. PubMed ID: 36508454
[TBL] [Abstract][Full Text] [Related]
70. Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency and Gametocytemia in a Pre-Elimination, Low Malaria Transmission Setting in Southern Zambia.
Kobayashi T; Kurani S; Hamapumbu H; Stevenson JC; Thuma PE; Moss WJ;
Am J Trop Med Hyg; 2021 Jan; 104(3):1000-1002. PubMed ID: 33399042
[TBL] [Abstract][Full Text] [Related]
71. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
[TBL] [Abstract][Full Text] [Related]
72. Implementation of G6PD testing and primaquine for
Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
[TBL] [Abstract][Full Text] [Related]
73. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
Howes RE; Piel FB; Patil AP; Nyangiri OA; Gething PW; Dewi M; Hogg MM; Battle KE; Padilla CD; Baird JK; Hay SI
PLoS Med; 2012; 9(11):e1001339. PubMed ID: 23152723
[TBL] [Abstract][Full Text] [Related]
74. Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India.
Anvikar AR; Sahu P; Pradhan MM; Sharma S; Ahmed N; Yadav CP; Pradhan S; Duparc S; Grewal Daumerie P; Valecha N
Am J Trop Med Hyg; 2022 Jan; 106(3):831-840. PubMed ID: 35008062
[TBL] [Abstract][Full Text] [Related]
75. The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on hemoglobin levels in Ethiopia: a longitudinal cohort study.
Habtamu K; Getachew H; Abossie A; Demissew A; Tsegaye A; Degefa T; Wang X; Lee MC; Zhou G; Kibret S; King CL; Kazura JW; Petros B; Yewhalaw D; Yan G
Res Sq; 2024 Mar; ():. PubMed ID: 38559068
[TBL] [Abstract][Full Text] [Related]
76. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
[TBL] [Abstract][Full Text] [Related]
77. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
[TBL] [Abstract][Full Text] [Related]
79. Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
Howes RE; Chan ER; Rakotomanga TA; Schulte S; Gibson J; Zikursh M; Franchard T; Ramiranirina B; Ratsimbasoa A; Zimmerman PA
Malar J; 2017 Apr; 16(1):139. PubMed ID: 28376871
[TBL] [Abstract][Full Text] [Related]
80. [Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day].
Silva MC; Santos EB; Costal EG; Filho MG; Guerreiro JF; Póvoa MM
Rev Soc Bras Med Trop; 2004; 37(3):215-7. PubMed ID: 15330059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
